The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

An open-label, randomized phase III trial of gemcitabine and carboplatin (GC) followed by Epstein-Barr virus-specific autologous cytotoxic t lymphocytes (EBV-CTLs) versus GC as front-line therapy for patients (pts) with advanced nasopharyngeal carcinoma (NPC).

Han Chong  Toh

Employment - Tessa Therapeutics

Leadership - Tessa Therapeutics

Stock and Other Ownership Interests  - Tessa Therapeutics

Speakers' Bureau - Kalbe Farma

Research Funding - Tessa Therapeutics

Patents, Royalties, Other Intellectual Property - Tessa Therapeutics

Travel, Accommodations, Expenses - Tessa Therapeutics

Josemund  Menezes

Employment - Tessa Therapeutics

Speakers' Bureau - Tessa Therapeutics

Travel, Accommodations, Expenses - Tessa Therapeutics